Cargando…
BMP9 mediates the anticancer activity of evodiamine through HIF-1α/p53 in human colon cancer cells
Colon cancer is one of the most common malignancies. Although there has been great development in treatment regimens over the last few decades, its prognosis remains poor. There is still a clinical need to find new drugs for colon cancer. Evodiamine (Evo) is a quinolone alkaloid extracted from the t...
Autores principales: | Li, Fu-Shu, Huang, Jun, Cui, Mao-Zhi, Zeng, Jin-Ru, Li, Pei-Pei, Li, Ling, Deng, Yan, Hu, Ying, He, Bai-Cheng, Shu, De-Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967201/ https://www.ncbi.nlm.nih.gov/pubmed/31894286 http://dx.doi.org/10.3892/or.2019.7427 |
Ejemplares similares
-
PTEN Reduces BMP9-Induced Osteogenic Differentiation Through Inhibiting Wnt10b in Mesenchymal Stem Cells
por: Li, Fu-Shu, et al.
Publicado: (2021) -
Evodiamine and Rutaecarpine as Potential Anticancer Compounds: A Combined Computational Study
por: Liu, Jingli, et al.
Publicado: (2022) -
Evaluation of the Cardiotoxicity of Evodiamine In Vitro and In Vivo
por: Yang, Weifeng, et al.
Publicado: (2017) -
BMP9-ID1 Signaling Activates HIF-1α and VEGFA Expression to Promote Tumor Angiogenesis in Hepatocellular Carcinoma
por: Chen, Han, et al.
Publicado: (2022) -
HIF1α Promotes BMP9-Mediated Osteoblastic Differentiation and Vascularization by Interacting with CBFA1
por: Li, Yuwan, et al.
Publicado: (2022)